tiprankstipranks
ME Therapeutics Holdings, Inc. (TSE:METX)
:METX
Canadian Market
Holding TSE:METX?
Track your performance easily

ME Therapeutics Holdings, Inc. (METX) Income Statement

8 Followers

ME Therapeutics Holdings, Inc. Income Statement

Last quarter (Q4 2024), ME Therapeutics Holdings, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q4, ME Therapeutics Holdings, Inc.'s net income was $-312.04K. See ME Therapeutics Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Aug 24Aug 23Sep 22
Total Revenue
$ ―$ ―$ ―$ ―
Cost of Revenue
$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―
Operating Expense
$ 1.37M$ 1.37M$ 6.54M$ 60.28K
Operating Income
$ -1.37M$ -1.37M$ -6.54M$ -60.28K
Net Non Operating Interest Income Expense
$ 31.82K$ 31.82K$ 3.95K$ 2.82K
Other Income Expense
$ -46.78K$ -46.78K$ -20.00K$ ―
Pretax Income
$ -1.29M$ -1.29M$ -6.52M$ -57.46K
Tax Provision
$ ―$ ―$ ―$ ―
Earnings From Equity Interest Net Of Tax
$ ―$ ―$ ―$ ―
Net Income Common Stockholders
$ -1.29M$ -1.29M$ -6.52M$ -57.46K
Basic EPS
$ -0.05$ -0.05$ -0.42$ -0.01
Diluted EPS
$ -0.05$ -0.05$ -0.42$ -0.01
Basic Average Shares
$ 97.44M$ 24.36M$ 15.63M$ 4.99M
Diluted Average Shares
$ 97.44M$ 24.36M$ 15.63M$ 4.99M
Dividend Per Share
$ ―$ ―$ ―$ ―
Total Operating Income As Reported
$ ―$ ―$ ―$ ―
Reported Normalized Basic E P S
$ ―$ ―$ ―$ ―
Reported Normalized Diluted E P S
$ ―$ ―$ ―$ ―
Rent Expense Supplemental
$ ―$ ―$ ―$ ―
Total Expenses
$ 1.37M$ 1.37M$ 6.54M$ ―
Net Income From Continuing And Discontinued Operation
$ -1.29M$ -1.29M$ -6.52M$ -57.46K
Normalized Income
$ -1.28M$ -1.28M$ -4.79M$ -42.23K
Interest Expense
$ ―$ ―$ ―$ ―
EBIT
$ -1.29M$ -1.29M$ -6.51M$ -57.46K
EBITDA
$ -1.29M$ -1.29M$ -6.51M$ -57.46K
Currency in USD

ME Therapeutics Holdings, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis